Brief: Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting
05/08/2026 10:05
BRIEF-Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting Aug 5 (Reuters) - Nanoform Finland Oyj NANOFH.HE:
INSIDE INFORMATION: POSITIVE FEEDBACK FROM UK MHRA SCIENTIFIC ADVICE MEETING REGARDING NANOENZALUTAMIDE
UK MHRA INDICATES HYBRID PATHWAY POSSIBLE FOR NANOENZALUTAMIDE MARKETING AUTHORIZATION
Source text: ID:nMFN1ws4w3
Further company coverage: NANOFH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nanoform Finland Oyj
See all newsFinland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cuts
Brief: Nanoform Q2 EBITDA EUR -3 Million
Brief: Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting
Finland's Nanoform Q1 revenue rises 45%, EBITDA loss narrows
Brief: Nanoform Finland Targets Cash Burn Below EUR 10 Mln For 2026